Abecmaidecabtagene vicleucel · BCMA CAR-TNot explicitly stated; mouse MED 6.16x10^5 CAR+ cells corresponds to HED 2.05x10^8 CAR+ T cells (100 kg)
ChondroCelectcharacterised viable autologous cartilage cells · Autologous chondrocytesClinical dose 0.8-1 x10^6 cells/cm2 based on animal studies, literature and ACI experience (not a formal FIH calculation)
Lantidradonislecel · Allogeneic pancreatic isletsNo nonclinical basis; target 10,000 EIN/kg from prior Edmonton Protocol clinical experience
Ryoncilremestemcel-L · Allogeneic BM-MSCNo formal dose-finding; 2x10^6 cells/kg clinical dose from earlier clinical/expanded access experience, not nonclinically derived
Tregziallogeneic Treg immunotherapy with HSPC and T cells (Orca-T) · Allogeneic Treg + HSPC + TconNo nonclinical basis; Phase 1/2 clinical safety data with a similar product supported the Phase 1b dose levels
Gintuitallogeneic cultured keratinocytes and fibroblasts in bovine collagen · Allogeneic keratinocytes + fibroblastsNot stated in public reviews
Holoclarautologous corneal epithelial cells containing limbal stem cells · Autologous limbal stem cellsNot stated in public reviews
MACIautologous cultured chondrocytes on porcine collagen membrane · Autologous chondrocytesNot stated in public reviews
Spheroxspheroids of autologous matrix-associated chondrocytes · Autologous chondrocyte spheroidsNot stated in public reviews
StrataGraftallogeneic cultured keratinocytes and dermal fibroblasts in murine collagen · Allogeneic keratinocytes + fibroblastsNot stated in public reviews
Zalmoxisallogeneic T cells modified with HSV-TK / dLNGFR (nalotimagene carmaleucel) · HSV-TK suicide-gene T cellsNot stated in public reviews